Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Patients’ daily reporting of symptoms via mobile application reveals a significant difference between patients’ perceptions and doctors’ interpretations
Authors:ID Grašič-Kuhar, Cvetka (Author)
ID Privšek, Nina (Author)
ID Sraka, Marjetka (Author)
ID Grašič, Ema (Author)
ID Kovač, Timotej (Author)
ID Kukar, Matjaž (Author)
Files:URL URL - Source URL, visit https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1595322/full
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo OI - Institute of Oncology
Abstract:Electronic patient-reported outcomes (ePROs) are gaining importance. The aim of this study was to investigate the difference in the reporting of symptoms between patients via mobile application (m-app) and doctor assessments. Additionally, usability and satisfaction with the use of the m-app were assessed. Methods: In this single-center prospective cohort study, we analyzed ePROs in 46 patients receiving (neo)adjuvant chemotherapy for early breast cancer. Patients recorded the occurrence and intensity of symptoms via the Android-based m-app daily. Three-monthly, patients completed validated quality of life questionnaires (EORTC C30 and BR23). For the 10 most common symptoms reported by patients, we compared the frequencies and grades between patients and doctors. Additionally, we compared daily symptom reports with questionnaire results. Finally, the usefulness of and level of satisfaction with the m-app by patients and doctors were evaluated. Results: During the study, patients recorded almost twice as many different symptoms through the m-app as doctors did in the electronic health records (75 vs 49). Symptoms were described by patients as mild (67%), moderate (30%), or severe (3%). The frequency and intensity of symptoms reported by patients were significantly higher than those reported by doctors (p<0.001). Fatigue, insomnia and dry mouth were the three main symptoms reported in more than 75% of patients, but insomnia and dry mouth were also the symptoms most often underreported by doctors. After three months of chemotherapy, QoL assessments revealed worsening of physical, social, cognitive and role functioning, increased fatigue, systemic therapy side effects, and dyspnea but a reduction in arm and shoulder problems. Patients and doctors rated the m-app with an overall score of 4.5 out of 5 (IQR 1.0). Patients expressed high levels of satisfaction with and usability of the m-app. In contrast, doctors were somewhat reluctant to perceive ePROs as an additional burden with patient management. Conclusion: This study revealed a significant discrepancy between patients’ daily symptom reports via the m-app and doctors’ assessments, indicating that healthcare professionals may not fully capture patients’ experiences. This underscores the importance of integrating PROs to accurately evaluate patients’ conditions. Our m-app serves as a promising tool for reporting and managing side effects during systemic treatment of breast cancer.
Keywords:breast cancer, mobile application, patients, doctors
Publication status:Published
Publication version:Version of Record
Submitted for review:17.03.2025
Article acceptance date:17.06.2025
Publication date:08.07.2025
Publisher:Frontiers Media SA
Year of publishing:2025
Number of pages:str. 1595322-1-1595322-14
Numbering:Vol. 15
PID:20.500.12556/DiRROS-24409 New window
UDC:616-006
ISSN on article:2234-943X
DOI:10.3389/fonc.2025.1595322 New window
COBISS.SI-ID:243217155 New window
Copyright:by Authors
Note:Nasl. z nasl. zaslona; Opis vira z dne 21. 7. 2025;
Publication date in DiRROS:05.12.2025
Views:77
Downloads:24
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Frontiers in oncology
Shortened title:Front. oncol.
Publisher:Frontiers Editorial Office
ISSN:2234-943X
COBISS.SI-ID:1601583 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0321-2020
Name:Napovedni dejavniki poteka bolezni in odgovora na zdravljenje pri različnih vrstah raka

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P2-0209-2022
Name:Umetna inteligenca in inteligentni sistemi

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:rak dojke, mobilne aplikacije, bolniki, zdravniki


Back